The treatment of Guillain-Barre can be clinically categorized into cause-specific treatment and supportive treatment. Supportive therapy is very important in the treatment of patients with Guillain-Barre, especially in patients with motor involvement, patients may have respiratory failure and need mechanical ventilation if necessary, and patients also have autonomic symptoms, and should be given symptomatic treatment according to their condition. For the cost of supportive treatment, if mechanical ventilation is needed, the cost will be more expensive, usually around 10,000 yuan. For the treatment of the cause of the disease, clinically, Griseofulvin is considered to be related to immunity, and the treatment methods include plasma exchange, cerebrospinal fluid filtration, intravenous gammaglobulin, and hormone therapy is also applied to some patients. For plasma exchange or intravenous gammaglobulin, the clinical cost is relatively high, ranging from 20-40 thousand dollars. If hormone therapy is utilized the cost is relatively or lower, possibly a few thousand dollars, but for curing Griseofulvin the cost ranges from about$20-50,000, which has a direct correlation with the patient’s condition.